LeafNLP Demos
Back to explore

Report #2887898

Received Mar 6, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Feb 27, 2026
Onset
Feb 27, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKZ014435—

Symptoms (1)

Pyrexia

Symptom narrative

14-month-old female, experienced a fever the first day; Medical Assistant/Manager reports another medical assistant accidentally used BEYFORTUS 100mg (Sanofi) to reconstitute PROQUAD, she states the Medical Assistant thought it was STERILE DILUENT. Patient was called and they were informed the patient, a; This spontaneous report was received from other health professional and refers to a 14-month-old female patient. The patient's concurrent conditions included Pneumonia. The patient's medical history and concomitant therapies were not reported. On 27-Feb-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), lot #Z014435 has been verified to be a valid lot number, expiration date: 11-Mar-2027, administered at a dose of 0.5 mL for prophylaxis. The vaccine administered was accidentally reconstituted with nirsevimab (BEYFORTUS) lot #UK429AA, expiration date: 31-Dec-2027 (dose, indication, anatomical site of injection and route of administration were not reported) (Product preparation error). On 27-Feb-2026 (reported as the first day), the patient experienced a fever (pyrexia). At the reporting time, the outcome of the event was unknown. The causal relationship between the event of fever and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live was not provided.

Current illness

Pneumonia

Other medications

BEYFORTUS